耳穴皮内针联合SSRIs治疗抑郁障碍的随机对照初步研究
治疗2周后,AIA组HAMD-17和SDS评分较基线的下降显著大于假AIA组,睡眠障碍临床显著反应率有更高趋势但未达统计学显著,两组均无不良事件。
要点
- 耳穴皮内针联合SSRIs在2周时HAMD-17和SDS减分优于单用SSRIs加假针。
- 睡眠障碍的临床显著反应率AIA组更高,但p=0.07未达统计学显著。
- 两组均未报告不良事件,提示短期耐受性良好。
核心结论
- 根据该初步研究,耳穴皮内针相较单用SSRIs在抑郁障碍治疗中可能具有附加价值。
研究设计与样本
- 两组均接受SSRIs常规治疗,AIA组接受耳穴皮内针刺激,假AIA组接受不刺入皮肤的贴附针。
- 每次留针4小时,每周5次,总疗程2周,在第0、1、2周采用HAMD-17、其5个因子及SDS评估。
主要发现
- 第2周时AIA组HAMD-17评分较基线的下降显著大于假AIA组(p=0.03)。
- 第2周时AIA组SDS评分较基线的下降显著大于假AIA组(p=0.02)。
- AIA组睡眠障碍的临床显著反应率高于假AIA组(p=0.07)。
- 两组均未发生不良事件。
关键数值与推荐
- 主要结局为HAMD-17总分及其5个因子(睡眠障碍、迟缓、认知功能障碍、焦虑/躯体化、体重)和SDS。
- AIA组与假AIA组第2周HAMD-17减分比较p=0.03,SDS减分比较p=0.02。
- 睡眠障碍临床显著反应率组间比较p=0.07。
临床怎么用
- 对于接受SSRIs治疗的抑郁障碍患者,可考虑联合耳穴皮内针作为辅助治疗以改善抑郁症状。
- 耳穴取穴关注迷走神经耳支和三叉神经支配区域。
- 每次留针4小时、每周5次、疗程2周的方案在本研究中未见不良事件,可作为临床参考。
局限性
- 采用单盲设计,假AIA为不刺入皮肤的贴附针。
- 疗程仅2周,缺乏长期疗效和随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the antidepressant effects of auricular intradermal acupuncture (AIA) of areas innervated by both the auricular branch of the vagus nerve and the trigeminal nerve. METHODS: Forty-nine patients with depression were randomly allocated into an AIA group (n = 25) and a sham AIA group (n = 24). Both groups received selective serotonin reuptake inhibitors (SSRIs) as conventional treatment. The AIA group received AIA stimulation, and the sham AIA group received sham AIA, which constituted being subjected to an attached needle that did not penetrate the skin. The needles were retained for 4 h each session, with five sessions a week for a total duration of 2 weeks. The outcomes were assessed by the 17-item Hamilton depression rating scale (HAMD-17), five factors (sleep disorder, retardation, cognitive dysfunction, anxiety/somatization, and weight) and self-rating depression scale (SDS) at weeks 0, 1, and 2. RESULTS: Fifty-four patients were randomly assigned to the AIA (n = 27) and sham AIA group (n = 27), of whom 25 patients in the AIA and 24 patients in the sham AIA group were analyzed. AIA-treated patients displayed a significantly greater reduction from baseline in HAMD-17 scores (p = 0.03) and SDS scores (p = 0.02) at week 2 compared to patients receiving sham AIA. The AIA intervention also produced a higher rate of clinically significant responses in sleep disorders (p = 0.07) compared to sham AIA. No adverse events occurred in either group. CONCLUSION: According to the findings of this preliminary study, AIA appears to have additional value compared to SSRIs alone in treating patients with depressive disorder.
引用
- Wang H, Liu XR, Wu XJ, et al. Additional value of auricular intradermal acupuncture alongside selective serotonin reuptake inhibitors: a single-blinded, randomized, sham-controlled preliminary clinical study. Acupunct Med. 2021. PMID: 33657871. doi:10.1177/0964528421997155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。